• Issue

    The Prostate: Volume 84, Issue 4

    315-413
    March 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 315
  • First Published: 24 January 2024

ORIGINAL ARTICLES

PrLZ regulates EMT and invasion in prostate cancer via the TGF-β1/p-smad2/miR-200 family/ZEB1 axis

Hongjun Xie PhD,  Jiaqi Chen PhD,  Zhenkun Ma PhD,  Yang Gao PhD,  Jin Zeng PhD,  Yule Chen PhD,  Zhao Yang PhD,  Shan Xu PhD, 
  • Pages: 317-328
  • First Published: 25 December 2023

4-Octyl itaconate alleviates experimental autoimmune prostatitis by inhibiting the NLRP3 inflammasome-induced pyroptosis through activating Nrf2/HO-1 pathway

Xiaohu Zhao MSc,  Rui Feng MSc,  Juan Chen PhD,  Qing Jiang MD, PhD,  Xiaoliang Hua,  Chaozhao Liang MD, PhD, 
  • Pages: 329-341
  • First Published: 10 December 2023

Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high-risk localized prostate cancer

Praful Ravi MRCP,  Lucia Kwak MS,  Wout Devlies MD,  Wanling Xie MS,  Fallon Chipidza MD,  Xiaoyu Yang MS,  Glenn Bubley MD,  Irving Kaplan MD,  Adam S. Kibel MD,  Paul Nguyen MD,  Mary-Ellen Taplin MD, 
  • Pages: 342-348
  • First Published: 01 December 2023

Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer

David Moon,  J. Spencer Hauck PhD,  Xue Jiang PhD,  Holly Quang,  Lingfan Xu MD,  Fan Zhang PhD,  Xia Gao PhD,  Robert Wild PhD,  Jeffrey I. Everitt DVM,  Everardo Macias PhD,  Yiping He PhD,  Jiaoti Huang MD/PhD, 
  • Pages: 349-357
  • First Published: 12 December 2023

Variable effects of periprostatic adipose tissue on prostate cancer cells: Role of adipose tissue lipid composition and cancer cells related factors

Mathilde Cancel MD, PhD,  David Crottes PhD,  Dorine Bellanger Ing,  Frank Bruyère MP, PhD,  Coralie Mousset Tech,  Michelle Pinault Ing,  Karine Mahéo PhD,  Gaëlle Fromont MD, PhD, 
  • Pages: 358-367
  • First Published: 19 December 2023
Open Access

Long term update on toxicity and survival of a phase II trial of linac-based stereotactic body radiation therapy for low-intermediate risk prostate cancer

Giuseppe R. D'Agostino MD, PhD,  Marco Badalamenti MD,  Sara Stefanini MD,  Davide Baldaccini MD,  Ciro Franzese MD,  Lorenzo Lo Faro MD,  Luciana Di Cristina MD,  Veronica Vernier MD,  Giacomo Reggiori PhD,  Marta Scorsetti MD, 
  • Pages: 368-375
  • First Published: 19 December 2023

Based on PI-RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20 ng/mL

Hua Huang MSc,  Zihao Liu PhD,  Yuan Ma PhD,  Yuan Shao MSc,  Zhen Yang MSc,  Dengyi Duan MSc,  Yang Zhao PhD,  Simeng Wen PhD,  Jing Tian PhD,  Yang Liu MSc,  Zeyuan Wang MSc,  Dan Yue MD, PhD,  Yong Wang MD, PhD, 
  • Pages: 376-388
  • First Published: 20 December 2023
Open Access

Emotion-centered versus fact-centered medical information to alleviate pain and anxiety in prostate biopsy: A randomized trial

Philipp Krausewitz MD,  Helene Schmeller MD,  Carsten Spitzer,  Jörg Ellinger,  Manuel Ritter,  Katja Petrowski,  Rupert Conrad, 
  • Pages: 389-394
  • First Published: 20 December 2023

A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer

Alexander Lukez MD,  Elizabeth Handorf PhD,  Nancy P. Mendenhall MD,  Randal H. Henderson MD, MBA,  Bradley J. Stish MD,  Brian J. Davis MD, PhD,  Mark Hallman MD, PhD,  Eric M. Horwitz MD,  Neha Vapiwala MD,  Jessica Karen Wong MD, MEng, 
  • Pages: 395-402
  • First Published: 18 December 2023

A prospective, randomized, open-label, parallel trial comparing the efficacy of α-blocker or 5α-reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyperplasia

Kwang Suk Lee MD, MMed,  Jeong Woo Yoo MD, MMSc,  Dae Ho Kim MD, MMSc,  Soyoung Jeon PhD,  Juyeon Yang MS,  Byung Ha Chung MD, PhD,  Kyo Chul Koo MD, PhD, 
  • Pages: 403-413
  • First Published: 27 December 2023